Serum a‐1 antitrypsin as a novel biomarker in chronic heart failure
Abstract Aims Chronic heart failure (CHF) remains a major health issue worldwide. In the present study, we aimed to identify novel circulating biomarkers for CHF using serum proteomics technology and to validate the biomarker in three independent cohorts. Methods and results The isobaric tags for re...
Main Authors: | Ying‐Ying Zheng, Ting‐Ting Wu, Xian‐Geng Hou, Hai‐Tao Yang, Yi Yang, Wen‐Juan Xiu, Ying Pan, Yi‐Tong Ma, Ailiman Mahemuti, Xiang Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14451 |
Similar Items
-
Treatment response in recent‐onset heart failure with reduced ejection fraction: non‐ischaemic vs. ischaemic aetiology
by: Jonas Silverdal, et al.
Published: (2023-02-01) -
Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01) -
PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01) -
Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non‐ischaemic heart failure
by: Elric Zweck, et al.
Published: (2023-04-01) -
Association of anaemia and all‐cause mortality in patients with ischaemic heart failure varies by renal function status
by: Anping Cai, et al.
Published: (2021-06-01)